Quality control of optimized hepatitis B plasmid DNA vaccine

  • Mounir M
  • Y J
  • Fars A
  • et al.
Citations of this article
Mendeley users who have this article in their library.


DNA vaccination and gene therapy using plasmid DNA [pDNA] are emerging as the tools of choice for preventing and treating debilitating diseases. A crucial issue in manufacturing pharmaceutical grade pDNA is quality control to fulfill the requirements of regulatory agency for purity, potency, safety and efficacy. Among the criteria that pDNA used for vaccination needs to meet, in full integrity of the DNA sequence to be injected. To control this parameter, a number of validated analytical methods are currently available. In this paper, we describe the molecular biology techniques used to control the quality and integrity of a hepatitis B DNA vaccine plasmid gWizHBs. To carry out this work, we have sequentially propagated gWizHBs in Escherichia coli DH5? and analyzed the plasmid preparation, by agarose gel electrophoresis, DNA restriction profiling and DNA sequencing. In addition to this generic technical platform, we have also discussed the limitation of the current DNA sequencing technique used in quality control of plasmid DNA for vaccination and suggest the use of pyrosequencing as a surrogate to Sanger DNA sequencing technique in order to control pDNA-based vaccines. The quality of the DNA vaccine met the requirements for medical use. ? 2012 Academic Journals.




Mounir, M. S. B., Y, J., Fars, A. A., Mohsen, B., Ibrahib, A., & M, D. F. (2012). Quality control of optimized hepatitis B plasmid DNA vaccine. African Journal of Biotechnology, 11(5), 1231–1239. https://doi.org/10.5897/ajb11.2924

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free